Pursuant to the provisions of Regulations 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Prism Medico and pharmacy has informed that the Board of Directors in their meeting held on Wednesday, 30th May at 4:00 pm and concluded at 5.00 pm; Considered and Approved and taken on records the standalone and consolidated Audited Financial Results along with Audit Report for the quarter and Financial Year ended on March 31, 2018 as recommended by the Audit Committee; Considered and approved the date of Annual General Meeting and the same shall to be held on 12th July, 2018; Considered and approved the name change of the Company from Prism Medico and Pharmacy to Prism Industries subject to the approval of the Registrar of Companies, Punjab & Chandigarh and the approval of the members.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: